Can rhodiola root extract cause ovarian cysts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Evidence That Rhodiola Root Extract Causes Ovarian Cysts

Based on available evidence, rhodiola root extract does not cause ovarian cysts. There is no documented causal relationship between rhodiola supplementation and ovarian cyst formation in the medical literature.

Evidence Review

The guideline evidence from the American Journal of Kidney Diseases 1 lists rhodiola among dietary supplements evaluated for various effects, noting only a drug-drug interaction concern (21% decrease in CYP2C9 activity with 580 mg/day for 14 days). Critically, there is no mention of ovarian cysts or any reproductive organ pathology associated with rhodiola use.

Research examining rhodiola's effects on reproductive tissues shows:

  • Breast tissue studies 2 demonstrate estrogenic activity in ER+ breast cancer cells initially, but longer treatment (2 weeks) actually reduced proliferation and tumorsphere formation, suggesting protective rather than proliferative effects
  • PCOS management literature 3, 4 actually positions herbal medicines, including various adaptogenic herbs, as potential treatments for polycystic ovary syndrome rather than causative agents
  • Clinical efficacy reviews 5, 6 document extensive traditional and clinical use for stress, fatigue, depression, and cognitive function with no reported adverse effects on ovarian tissue

Clinical Context

The confusion may arise from:

  • Misunderstanding PCOS pathophysiology: Ovarian cysts in PCOS result from hormonal imbalances (hyperandrogenism, insulin resistance, anovulation), not from external substances 7
  • Estrogenic activity concerns: While rhodiola shows some estrogenic effects in vitro 2, this does not translate to cyst formation—in fact, the longer-term effects appear anti-proliferative

Safety Profile

Multiple clinical trials 5, 6, 8 demonstrate rhodiola's safety profile with:

  • No significant adverse effects reported
  • No drug interactions affecting reproductive hormones
  • Traditional use spanning decades without documented ovarian pathology

If a patient develops ovarian cysts while taking rhodiola, investigate standard PCOS risk factors (obesity, insulin resistance, hyperandrogenism) rather than attributing causation to the supplement 7.

References

Guideline

use of dietary supplements in living kidney donors: a critical review.

American Journal of Kidney Diseases, 2020

Research

Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.